Template:Dgfn2015 Mo 7:00 PCSK9
(Difference between revisions)
Ossip Groth (Talk | contribs) (Created page with "{{tp|p=12612979|t=A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease |pdf=http://linkinghub.elsevier.com/retrieve/...") |
Ossip Groth (Talk | contribs) |
||
Line 16: | Line 16: | ||
{{tp|p=16554535|t=Protease variants, LDL, and coronary heart disease |pdf=http://www.nejm.org/doi/full/10.1056/NEJMe068026|usr=|}} | {{tp|p=16554535|t=Protease variants, LDL, and coronary heart disease |pdf=http://www.nejm.org/doi/full/10.1056/NEJMe068026|usr=|}} | ||
+ | |||
+ | {{tp|p=17200716|t=Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia |pdf=http://www.jci.org/articles/view/29415/pdf|usr=|}} | ||
+ | |||
+ | {{tp|p=12730697|t=Mutations in PCSK9 cause autosomal dominant hypercholesterolemia |pdf=http://www.nature.com/ng/journal/v34/n2/full/ng1161.html|usr=|}} | ||
+ | |||
+ | {{tp|p=23973703|t=Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis |pdf=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(13)03099-4|usr=|}} | ||
+ | |||
+ | {{tp|p=19191301|t=Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease |pdf=http://onlinelibrary.wiley.com/doi/10.1002/humu.20882/pdf|usr=|}} | ||
+ | |||
+ | {{tp|p=16554528|t=Sequence variations in PCSK9, low LDL, and protection against coronary heart disease |pdf=http://www.nejm.org/doi/pdf/10.1056/NEJMoa054013|usr=|}} | ||
+ | |||
+ | {{tp|p=20031607|t=Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study |pdf=http://circgenetics.ahajournals.org/content/2/4/354.full.pdf+html|usr=|}} |
Revision as of 13:32, 14 September 2015
Journal article, free access |
GET A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Extract PDF direct |
Journal article, free access |
GET Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates Extract PDF direct |
Journal article, free access |
GET The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Extract PDF direct |
Journal article, free access |
GET Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Extract PDF direct |
Journal article, free access |
GET A century of cholesterol and coronaries: from plaques to genes to statins Extract PDF direct |
Journal article, free access |
GET Targeting PCSK9 for hypercholesterolemia Extract PDF direct |
Journal article, free access |
GET The biology and therapeutic targeting of the proprotein convertases Extract PDF direct |
Journal article, free access |
GET Plasma membrane CD81 complexes with PCSK9 and LDLR and its levels are reduced by PCSK9 Extract PDF direct |
Journal article, free access |
GET Protease variants, LDL, and coronary heart disease Extract PDF direct |
Journal article, free access |
GET Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia Extract PDF direct |
Journal article, free access |
GET Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Extract PDF direct |
Journal article, free access |
GET Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis Extract PDF direct |
Journal article, free access |
GET Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease Extract PDF direct |
Journal article, free access |
GET Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Extract PDF direct |
Journal article, free access |
GET Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study Extract PDF direct |